CDC’s Role in Ending the HIV Epidemic
CDC works closely with state and local governments, people with and at risk for HIV, as well as federal partners to coordinate efforts on expanding the use of the highest-impact HIV prevention strategies: Diagnose; Treat; Prevent; and Respond. As needed, CDC will assist each jurisdiction to address gaps in their local workforce.
Ending the HIV Epidemic aims to infuse priority areas with additional resources, technology, and expertise that scale up the use of the four strategies. In July 2020, CDC awarded approximately $109 million to begin the first-year of a five-year funding program entitled “Integrated HIV Programs for Health Departments to Support Ending the HIV Epidemic in the United States (PS20-2010).”
EHE jurisdictions are developing local plans outlining how they will apply these strategies in ways that account for local challenges and opportunities in HIV prevention. With support from CDC and other federal agencies, local staff will lead strengthened, culturally competent, multi-disciplinary teams to carry out activities in their communities.
Local activities must be informed by input from longstanding and new voices in HIV prevention and treatment, including people with and at risk for HIV; primary and HIV-specialty care providers; tribal governments and/or tribally designated organizations; community- and faith-based organizations; education agencies; and others.
In addition to working on HIV, awardees receiving funding are also confronting COVID-19 in their jurisdictions. CDC recognizes that EHE-related activities may need to adapt to effectively balance the responses to COVID-19 and HIV. CDC is committed to moving forward with EHE and to providing state and local communities the support and flexibility they need to address new and evolving challenges.
While the specifics of implementation will differ by jurisdiction and funding, each community will be working to scale up four key strategies which together can end the epidemic:
Prevent new HIV transmissions by using proven interventions, including PrEP and syringe services programs (SSPs).